Roger Crystal
Net Worth

Last updated:

What is Roger Crystal net worth?

The estimated net worth of Dr. Roger Crystal is at least $7,627,016 as of 27 Jan 2023. He has earned $262,376 from insider trading and has received compensation worth at least $7,364,640 in Opiant Pharmaceuticals, Inc..

What is the salary of Roger Crystal?

Dr. Roger Crystal salary is $920,580 per year as Pres, Chief Executive Officer & Director in Opiant Pharmaceuticals, Inc..

How old is Roger Crystal?

Dr. Roger Crystal is 49 years old, born in 1976.

What stocks does Roger Crystal currently own?

As insider, Dr. Roger Crystal owns shares in one company:

Company Title Shares Price per share Total value
Opiant Pharmaceuticals, Inc. (OPNT) Pres, Chief Executive Officer & Director 75,339 $0 $0

What does Opiant Pharmaceuticals, Inc. do?

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

OPNT logo
OPNT
Opiant Pharmaceuticals, Inc.

Roger Crystal insider trading

Opiant Pharmaceuticals, Inc.

Dr. Roger Crystal has made 20 insider trades between 2017-2023, according to the Form 4 filled with the SEC. Most recently he sold 1,358 units of OPNT stock worth $27,513 on 27 Jan 2023.

The largest trade he's ever made was exercising 50,000 units of OPNT stock on 2 Oct 2018. As of 27 Jan 2023 he still owns at least 75,339 units of OPNT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,358 $20.26 $27,513
Sale
Common Stock 1,183 $20.2 $23,897
Sale
Common Stock 5,029 $20.2 $101,586
Sale
Common Stock 2,246 $11.11 $24,953
Sale
Common Stock 1,995 $26.15 $52,169
Sale
Common Stock 1,058 $30.49 $32,258
Purchase
Common Stock par value $0.001 100 $23.44 $2,344
Sale
Common Stock 12,772 N/A N/A
Option
Option 21,472 N/A N/A
Option
Common Stock 21,472 N/A N/A
Sale
Common Stock 16,001 N/A N/A
Sale
Common Stock 16,836 N/A N/A
Option
Option 22,557 N/A N/A
Option
Common Stock 22,557 N/A N/A
Option
Common Stock 5,149 N/A N/A
Option
Option 5,149 N/A N/A
Sale
Common Stock 3,791 N/A N/A
Sale
Common Stock 600 N/A N/A
Option
Common Stock 822 N/A N/A
Option
Option 822 N/A N/A
Sale
Common Stock 11,407 N/A N/A
Sale
Common Stock 26,759 N/A N/A
Option
Option 8,641 N/A N/A
Option
Common Stock 33,641 N/A N/A
Sale
Common Stock 11,834 N/A N/A
Option
Common Stock 16,359 N/A N/A
Option
Option 41,359 N/A N/A
Sale
Common Stock 6,941 N/A N/A
Sale
Common Stock 3,059 N/A N/A
Sale
Common Stock 847 N/A N/A
Sale
Common Stock 4,006 N/A N/A
Sale
Common Stock 4,300 N/A N/A
Option
Common Stock 29,297 N/A N/A
Option
Option 50,000 N/A N/A
Sale
Common Stock 10,144 N/A N/A
Purchase
Common Stock 3,475 N/A N/A

Opiant Pharmaceuticals key executives

Opiant Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: